Cyclin D kinase 4/6 (CDK4/6) specifically regulates the transition of cells from the G1 to S phase, and CDK4/6 inhibitors block this process and effectively block the proliferation of sensitive cancer cells.99 This evidence concerns the gene CDK4 and cancer.